CLARIVATE PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.95 USD | +0.58% |
|
-5.44% | -24.95% |
| Mar. 21 | Clarivate to Acquire Substantial Majority of MotionHall's Assets | MT |
| Mar. 21 | Clarivate Plc entered into an agreement to acquire substantial majority of assets from MotionHall Inc. | CI |
ETFs positioned on Clarivate Plc
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 12.89% | 215 M€ | +12.86% | - | |
| 0.71% | 15 M€ | +2.15% | ||
| 0.67% | 3 M€ | -.--% | ||
| 0.21% | 18 M€ | +0.75% | - | |
| 0.05% | 9 M€ | +1.94% | - | |
| 0.05% | 736 M€ | +5.73% | ||
| 0.02% | 219 M€ | +17.17% | - | |
| 0.02% | 1,448 M€ | -.--% | - | |
| 0.01% | 2,658 M€ | +9.02% | - | |
| 0.01% | 2 M€ | +14.69% | - | |
| 0.01% | 29 M€ | -2.87% | - | |
| 0.01% | 1,006 M€ | -.--% | - | |
| 0.01% | 414 M€ | +9.07% | - | |
| 0.01% | 330 M€ | -.--% | - | |
| 0.01% | 273 M€ | +10.28% | ||
| 0.01% | 152 M€ | -3.25% | - | |
| 0.01% | 17 M€ | +1.04% | - | |
| 0.01% | 35 M€ | +8.78% | - | |
| 0.01% | 29 M€ | -.--% | - | |
| 0.01% | 322 M€ | +13.88% | - | |
| 0.00% | 607 M€ | +0.05% | - | |
| 0.00% | 1,166 M€ | +0.26% | - | |
| 0.00% | 34 M€ | +5.46% | - | |
| 0.00% | 389 M€ | +5.66% | - | |
| 0.00% | 302 M€ | +3.55% | - | |
| 0.00% | 39 M€ | +3.32% | - | |
| 0.00% | 8 M€ | -0.76% | - |
Clarivate Plc is an information services provider. The Company provides information, analytics, professional services and workflow solutions that enable users across government and academic institutions, life science and healthcare companies, corporations and law firms to power the entire lifecycle, from cultivating curiosity to protecting critical intellectual property assets. Its segments include Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H). The A&G segment provides curated, structured content, discovery solutions and related software applications that are embedded into the workflows of its customers, which include libraries, universities and research institutions. Its IP segment consists of patents, trademarks, and IP management products and solutions. The LS&H segment contains its products and solutions, which serve the content and analytical needs of pharmaceutical and biotechnology companies across the drug development lifecycle.
Calendar
2024-05-06
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
6.95
USD
Average target price
8.13
USD
Spread / Average Target
+16.98%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -24.95% | 4.62B | |
| -6.16% | 129B | |
| +7.27% | 68.87B | |
| -10.59% | 40.48B | |
| +9.87% | 35.92B | |
| -9.98% | 16.36B | |
| -2.47% | 13.52B | |
| +13.90% | 10.57B | |
| -21.79% | 4.01B | |
| +10.45% | 2.19B |
- Stock Market
- Equities
- CLVT Stock
- Funds and ETFs Clarivate Plc
